Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

4.860
+0.0901.89%
Volume:67.70M
Turnover:327.34M
Market Cap:56.10B
PE:9.16
High:4.870
Open:4.820
Low:4.790
Close:4.770
Loading ...

CSPC Pharmaceutical - CSPC Megalith Will Receive Upfront Payments of US$15 Mln

THOMSON REUTERS
·
19 Feb

CSPC Pharmaceutical's Unit Gets China Nod for Marketing of New Indication of Asthma Drug

MT Newswires Live
·
11 Feb

BRIEF-Cspc Pharmaceutical Says Syh2059 Tablets Obtains Clinical Trial Approval In U.S.

Reuters
·
10 Feb

BRIEF-Cspc Pharmaceutical Says Enyitan Obtains Marketing Approval By Nmpa

Reuters
·
10 Feb

CSPC Pharmaceutical - New Indication for Enyitan Obtains Marketing Approval by Nmpa

THOMSON REUTERS
·
10 Feb

CSPC Pharmaceutical - Syh2059 Tablets Obtains Clinical Trial Approval in U.S. by US FDA

THOMSON REUTERS
·
10 Feb

CSPC Pharmaceutical Group Limited's (HKG:1093) Share Price Not Quite Adding Up

Simply Wall St.
·
10 Feb

CSPC Pharmaceutical Get China Nod for Herpes Zoster Drug Trial

MT Newswires Live
·
07 Feb

BRIEF-CSPC Pharmaceutical Says Sys6017 Obtained Clinical Trial Approval From NMPA

Reuters
·
07 Feb

CSPC Pharmaceutical - Sys6017 (Herpes Zoster Mrna Vaccine) Obtains Clinical Trial Approval From Nmpa

THOMSON REUTERS
·
07 Feb

CSPC Pharmaceutical Gets China Nod for Registration of Tumor Drug

MT Newswires Live
·
21 Jan

BRIEF-Cspc Pharmaceutical Says Regorafenib Tablets Obtains Drug Registration Approval

Reuters
·
20 Jan

CSPC Pharmaceutical - Regorafenib Tablets Obtains Drug Registration Approval From Nmpa China

THOMSON REUTERS
·
20 Jan

BRIEF-CSPC Pharmaceutical Says Sys6043 Obtains Clinical Trial Approval

Reuters
·
16 Jan

CSPC Pharmaceutical Gets FDA Approval for Clinical Trial of Tumor Drug in US

MT Newswires Live
·
16 Jan

CSPC Pharmaceutical - Sys6043 (Antibody-Drug Conjugate) Obtains Clinical Trial Approval in U.S.

THOMSON REUTERS
·
16 Jan